Abstract
The WHO Model List of Essential Medicines provides a core list of medicines that are safe, cost-effective, and necessary to address major public health concerns.1 Including long-acting insulin analogues on the WHO Model List of Essential Medicines emphasises global inequities in insulin but does not profoundly change that the availability and affordability of all insulins is poor.2,3
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have